PPD Signs Risk-Sharing Deal with Indian Generics Company Ranbaxy
Wilmington, N.C.-based contract research organization (CRO) PPD has licensed investigational statin RBx-10558 from India-based generics company Ranbaxy Laboratories, which recently began developing novel drugs. inVentiv Health Makes Two More Acquisitions and Reports Strong Revenues
Somerset, N.J.-based inVentiv Health, a life science communications company with a contract research organization (CRO) unit, reported a nearly 40% jump in revenues to $766.2 million in 2006. For its fourth quarter, inVentiv reported revenues jumped 21% to $211.8 million.
